Filings

All 2026202520242023

Year	Client	Period	Income	Expenses	Doc
2023	ALNYLAM PHARMACEUTICALS, INC.	3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report	—	$220,000
2023	ALNYLAM PHARMACEUTICALS, INC.	3rd Quarter (July 1 - Sep 30) Registration	—	—

Prev Page 2 of 2  ·  12 filings

Clients Represented

Client	Filings	Total Income
ALNYLAM PHARMACEUTICALS, INC.	12	—

Lobbyists

Name	Disclosed Prior Position
DEIRDRE BRADFORD PARSONS
CURTIS RHYNE	Rep. Virginia Foxx (2008-2009), House Republican Study Committee (2009-2014), Rep. Richard Hudson (2014-2017), Rep. Geo…
CHASE THOMAS